Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 16, 2021; 9(20): 5462-5469
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5462
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5462
Group A (n = 19) | Group B (n = 28) | t- or χ2 value | P value | |
Age, yr | 64.68 ± 8.48 | 63.46 ± 6.53 | 0.56 | 0.58 |
Gender | 12 (63.2%) | 18 (64.3%) | 0.006 | 0.937 |
Mean Hospitalization stay, d | 11.56 ± 4.82 | 12.83 ± 5.35 | -0.80 | 0.429 |
Mechanical ventilation, n | 1 | 2 | - | 1.0 |
Intensive care unit, n | 1 | 2 | - | 1.0 |
Death, n | 1 | 2 | - | 1.0 |
- Citation: Li XL, Li T, Du QC, Yang L, He KL. Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19. World J Clin Cases 2021; 9(20): 5462-5469
- URL: https://www.wjgnet.com/2307-8960/full/v9/i20/5462.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i20.5462